Dr. Takeo Iwamoto holds a Doctor of Pharmacy and a PhD in biological engineering from Tokyo Institute of Technology. He served as a professor at Jikei University School of Medicine, specializing in Molecular Diagnosis and Therapy. Over three decades, he has collaborated with Professor John Tomich from Kansas State University, co-authoring 31 research papers and securing seven patents. Dr. Iwamoto’s research focuses on drug screening for rare diseases, utilizing patient-induced pluripotent stem (iPS) cells with FDA-approved drugs in Japan. His work aims to advance innovative therapies and improve treatment options for rare diseases.